10-Q



	September 30, 2015			December 31, 2014			September 30, 2014
ASSETS
Current assets:
Cash and cash equivalents	$	254.0		$	256.8		$	263.6
Receivables, net	300.4			263.1			333.4
Income taxes receivable	—			21.6			4.3
Inventories	232.5			210.1			198.8
Current deferred income taxes	69.1			54.2			45.8
Other current assets	12.4			10.3			11.1
Total current assets	868.4			816.1			857.0
Property, plant and equipment (less accumulated depreciation of $1,411.9, $1,330.7 and $1,324.6)	913.7			931.0			936.4
Prepaid pension costs	—			—			1.6
Restricted cash	—			—			2.0
Deferred income taxes	11.9			12.5			11.2
Other assets	167.7			191.4			197.7
Goodwill	747.1			747.1			747.1
Total assets	$	2,708.8		$	2,698.1		$	2,753.0
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current installments of long-term debt	$	143.3		$	16.4		$	16.4
Accounts payable	158.7			146.8			165.5
Income taxes payable	10.4			0.2			0.5
Accrued liabilities	272.8			214.3			209.2
Total current liabilities	585.2			377.7			391.6
Long-term debt	526.9			658.7			672.7
Accrued pension liability	97.2			182.0			64.7
Deferred income taxes	118.0			107.1			139.0
Other liabilities	335.4			359.3			363.8
Total liabilities	1,662.7			1,684.8			1,631.8
Commitments and contingencies
Shareholders’ equity:
Common stock, par value $1 per share: authorized, 120.0 shares; issued and outstanding 77.6, 77.4 and 78.2 shares	77.6			77.4			78.2
Additional paid-in capital	796.2			788.3			805.9
Accumulated other comprehensive loss	(433.2		)	(443.1		)	(356.4		)
Retained earnings	605.5			590.7			593.5
Total shareholders’ equity	1,046.1			1,013.3			1,121.2
Total liabilities and shareholders’ equity	$	2,708.8		$	2,698.1		$	2,753.0



	Three Months Ended September 30,					Nine Months Ended September 30,
	2015			2014		2015		2014
Sales	$	533.6		$	593.6	$	1,587.0	$	1,741.4
Operating expenses:
Cost of goods sold	460.0			492.3		1,338.7		1,431.3
Selling and administration	35.8			41.8		122.7		127.0
Restructuring charges	0.3			1.2		2.2		4.5
Acquisition-related costs	14.5			1.0		35.4		1.4
Other operating (expense) income	(0.1		)	—		42.1		0.8
Operating income	22.9			57.3		130.1		178.0
Earnings of non-consolidated affiliates	0.5			0.5		1.3		1.4
Interest expense	14.4			17.7		39.7		37.0
Interest income	0.3			0.2		0.9		0.9
Income from continuing operations before taxes	9.3			40.3		92.6		143.3
Income tax provision	3.4			14.2		31.3		51.1
Income from continuing operations, net	5.9			26.1		61.3		92.2
Income from discontinued operations, net	—			—		—		0.7
Net income	$	5.9		$	26.1	$	61.3	$	92.9
Net income per common share:
Basic income per common share:
Income from continuing operations, net	$	0.08		$	0.33	$	0.79	$	1.17
Income from discontinued operations, net	—			—		—		0.01
Net income	$	0.08		$	0.33	$	0.79	$	1.18
Diluted income per common share:
Income from continuing operations, net	$	0.08		$	0.33	$	0.78	$	1.15
Income from discontinued operations, net	—			—		—		0.01
Net income	$	0.08		$	0.33	$	0.78	$	1.16
Dividends per common share	$	0.20		$	0.20	$	0.60	$	0.60
Average common shares outstanding:
Basic	77.6			78.4		77.5		78.8
Diluted	78.3			79.5		78.5		80.0



	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Net income	$	5.9		$	26.1		$	61.3		$	92.9
Other comprehensive income, net of tax:
Foreign currency translation adjustments	(1.7		)	(1.5		)	(2.8		)	(0.5		)
Unrealized losses on derivative contracts	(2.1		)	(2.0		)	(2.6		)	(2.3		)
Amortization of prior service costs and actuarial losses	4.9			3.5			15.3			11.5
Total other comprehensive income, net of tax	1.1			—			9.9			8.7
Comprehensive income	$	7.0		$	26.1		$	71.2		$	101.6



	Common Stock					Additional Paid-In Capital			Accumulated Other Comprehensive Loss			Retained Earnings			Total Shareholders’ Equity
	Shares Issued		Par Value			Additional Paid-In Capital			Accumulated Other Comprehensive Loss			Retained Earnings			Total Shareholders’ Equity
Balance at January 1, 2014	79.4		$	79.4		$	838.8		$	(365.1	)	$	548.0		$	1,101.1
Net income	—		—			—			—			92.9			92.9
Other comprehensive income	—		—			—			8.7			—			8.7
Dividends paid:
Common stock ($0.60 per share)	—		—			—			—			(47.4		)	(47.4		)
Common stock repurchased and retired	(1.7	)	(1.7		)	(43.0		)	—			—			(44.7		)
Common stock issued for:
Stock options exercised	0.4		0.4			8.2			—			—			8.6
Other transactions	0.1		0.1			1.9			—			—			2.0
Balance at September 30, 2014	78.2		$	78.2		$	805.9		$	(356.4	)	$	593.5		$	1,121.2
Balance at January 1, 2015	77.4		$	77.4		$	788.3		$	(443.1	)	$	590.7		$	1,013.3
Net income	—		—			—			—			61.3			61.3
Other comprehensive income	—		—			—			9.9			—			9.9
Dividends paid:
Common stock ($0.60 per share)	—		—			—			—			(46.5		)	(46.5		)
Common stock issued for:
Stock options exercised	0.1		0.1			3.0			—			—			3.1
Other transactions	0.1		0.1			2.1			—			—			2.2
Stock-based compensation	—		—			2.8			—			—			2.8
Balance at September 30, 2015	77.6		$	77.6		$	796.2		$	(433.2	)	$	605.5		$	1,046.1



	Nine Months Ended September 30,
	2015			2014
Operating Activities
Net income	$	61.3		$	92.9
Adjustments to reconcile net income to net cash and cash equivalents provided by (used for) operating activities:
Earnings of non-consolidated affiliates	(1.3		)	(1.4		)
Gains on disposition of property, plant and equipment	(23.6		)	(0.6		)
Stock-based compensation	5.5			3.5
Depreciation and amortization	104.9			104.3
Deferred income taxes	(11.5		)	17.9
Qualified pension plan contributions	(0.5		)	(0.6		)
Qualified pension plan income	(21.0		)	(21.4		)
Change in:
Receivables	(37.3		)	(46.7		)
Income taxes receivable/payable	31.8			(10.2		)
Inventories	(22.4		)	(12.3		)
Other current assets	(2.7		)	0.9
Accounts payable and accrued liabilities	11.1			(12.0		)
Other assets	25.7			5.1
Other noncurrent liabilities	(5.4		)	(20.0		)
Other operating activities	0.5			0.1
Net operating activities	115.1			99.5
Investing Activities
Capital expenditures	(79.7		)	(49.7		)
Proceeds from disposition of property, plant and equipment	24.8			4.0
Proceeds from disposition of affiliated companies	6.6			—
Restricted cash activity	—			2.2
Other investing activities	(2.8		)	(0.5		)
Net investing activities	(51.1		)	(44.0		)
Financing Activities
Long-term debt:
Borrowings	—			150.0
Repayments	(3.2		)	(149.2		)
Earn out payment – SunBelt	—			(14.8		)
Common stock repurchased and retired	—			(44.7		)
Stock options exercised	2.2			6.5
Excess tax benefits from stock-based compensation	0.4			1.1
Dividends paid	(46.5		)	(47.4		)
Debt issuance costs	(19.7		)	(1.2		)
Net financing activities	(66.8		)	(99.7		)
Net decrease in cash and cash equivalents	(2.8		)	(44.2		)
Cash and cash equivalents, beginning of period	256.8			307.8
Cash and cash equivalents, end of period	$	254.0		$	263.6
Cash paid for interest and income taxes:
Interest	$	18.8		$	30.8
Income taxes, net of refunds	$	5.4		$	42.7
Non-cash investing activities:
Capital expenditures included in accounts payable and accrued liabilities	$	1.7		$	3.6

Olin Corporation (Olin) is a Virginia corporation, incorporated in 1892. We are a manufacturer concentrated in three business segments: Chlor Alkali Products, Chemical Distribution and Winchester. Chlor Alkali Products, with eight U.S. manufacturing facilities and one Canadian manufacturing facility, produces chlorine and caustic soda, hydrochloric acid, hydrogen, bleach products and potassium hydroxide. Chemical Distribution, with twenty-four owned and leased terminal facilities, manufactures bleach products and distributes caustic soda, bleach products, potassium hydroxide and hydrochloric acid. Winchester, with its principal manufacturing facilities in East Alton, IL and Oxford, MS, produces and distributes sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges.

We have prepared the condensed financial statements included herein, without audit, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The preparation of the consolidated financial statements requires estimates and assumptions that affect amounts reported and disclosed in the financial statements and related notes. In our opinion, these financial statements reflect all adjustments (consisting only of normal accruals), which are necessary to present fairly the results for interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations; however, we believe that the disclosures are appropriate. We recommend that you read these condensed financial statements in conjunction with the financial statements, accounting policies and the notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2014. Certain reclassifications were made to prior year amounts to conform to the 2015 presentation.

On October 5, 2015 (the Closing Date), Olin consummated the previously announced merger (the Merger) of our wholly owned subsidiary, Blue Cube Acquisition Corp. (Merger Sub), with and into Blue Cube Spinco Inc. (Spinco), with Spinco as the surviving corporation and a wholly owned subsidiary of Olin, as contemplated by the Agreement and Plan of Merger (the Merger Agreement) dated March 26, 2015, among Olin, The Dow Chemical Company (TDCC), Merger Sub and Spinco. Pursuant to the Merger Agreement and a Separation Agreement dated March 26, 2015 between TDCC and Spinco (the Separation Agreement), prior to the Merger, (1) TDCC transferred its U.S. chlor alkali and vinyl, global chlorinated organics and global epoxy businesses (collectively, the Acquired Business) to Spinco and (2) TDCC distributed Spinco’s stock to TDCC’s shareholders by way of a split-off (the Distribution). Upon consummation of the Transactions contemplated by the Merger Agreement and the Separation Agreement (the Transactions), the shares of Spinco common stock then outstanding were automatically converted into the right to receive approximately 87.5 million shares of Olin common stock, which were issued by Olin on the Closing Date, and represented approximately 53% of the outstanding shares of Olin common stock, together with cash in lieu of fractional shares. Olin’s pre-Merger shareholders continued to hold the remaining approximately 47% of the outstanding shares of Olin common stock. On the Closing Date, Spinco became a wholly owned subsidiary of Olin.

The aggregate purchase price for the Acquired Business of $5,069.8 million, subject to certain post-closing adjustments, consisted of $2,568.4 million of cash and debt transferred to TDCC, shares of Olin common stock received by TDCC shareholders valued at approximately $1,527.4 million, plus the assumption of pension liabilities of approximately $418.0 million and long-term debt of $556.0 million. TDCC retained liabilities relating to litigation, releases of hazardous materials and violations of environmental law to the extent arising prior to the Closing Date. The value of the common stock was based on the closing stock price on the last trade date prior to the Closing Date of $17.46. The initial accounting for the Transactions (including the allocation of the purchase price to acquired assets and liabilities) is not complete. Our operating results for the three and nine months ended September 30, 2015 and 2014 do not include the results of operations of the Acquired Business.

Prior to the Distribution, TDCC received from Spinco distributions of cash and debt instruments of Spinco with an aggregate value of $2,095.0 million (collectively, the Cash and Debt Distribution). On the Closing Date, Spinco issued $720.0 million aggregate principal amount of 9.75% senior notes due October 15, 2023 (2023 Notes) and $500.0 million aggregate principal amount of 10.00% senior notes due October 15, 2025 (2025 Notes and, together with the 2023 Notes, the Notes) to TDCC. TDCC transferred the Notes to certain unaffiliated securityholders in satisfaction of existing debt obligations of TDCC held or acquired by those unaffiliated securityholders. On October 5, 2015, certain initial purchasers purchased the Notes from the unaffiliated securityholders. Interest on the Notes will accrue from October 1, 2015 and will be paid semi-annually beginning on April 15, 2016. The Notes are not redeemable at any time prior to October 15, 2020. Neither Olin nor Spinco received any proceeds from the sale of the Notes. Upon the consummation of the Transactions, Olin became guarantor of the Notes. To satisfy the cash portion of the Cash and Debt Distribution, TDCC received from Spinco a total of $875.0 million immediately prior to the Distribution.

In connection with the Transactions, certain additional agreements have been entered into, including, among others, an Employee Matters Agreement, a Tax Matters Agreement and site, transitional and other services agreements, supply and purchase agreements, real estate agreements, technology licenses and intellectual property agreements. Payments of approximately $39.9 million, subject to certain post-closing adjustments, will be made as a result of the Transactions related to certain liabilities. In addition, Olin and TDCC have agreed in connection with the Transactions to enter into arrangements for the long-term supply of ethylene by TDCC to Olin, pursuant to which, among other things, Olin has made upfront payments of $433.5 million upon the closing of the Merger in order to receive ethylene at producer economics and for certain reservation fees for obtaining additional future ethylene supply at producer economics.

On June 23, 2015, Spinco entered into a new five-year delayed-draw term loan facility of up to $1,050.0 million. As of the Closing Date, Spinco drew $875.0 million to finance the cash portion of the Cash and Debt Distribution. Also on June 23, 2015, Olin and Spinco entered into a new five-year $1,850.0 million senior credit facility consisting of a $500.0 million senior revolving credit facility, which replaced Olin’s $265.0 million senior revolving credit facility at the closing of the Merger, and a $1,350.0 million (subject to reduction by the aggregate amount of the term loans funded to Spinco under the Spinco term loan facility) delayed-draw term loan facility. As of the Closing Date, an additional $475.0 million was drawn by Olin under this term loan facility which was used to pay fees and expenses of the Transactions, obtain additional funds for general corporate purposes and refinance Olin’s existing senior term loan facility due in 2019. The new senior credit facilities will expire in 2020. The $500.0 million senior revolving credit facility includes a $100.0 million letter of credit subfacility. The term loan facilities include amortization payable in equal quarterly installments at a rate of 5.0% per annum for the first two years, increasing to 7.5% per annum for the following year and to 10.0% per annum for the last two years. Under its applicable new senior credit facilities, Olin or Spinco, as the case may be, may select various floating rate borrowing options. The actual interest rate paid on borrowings under the applicable senior credit facilities is based on a pricing grid which is dependent upon the leverage ratio as calculated under the terms of the applicable facility for the prior fiscal quarter. The facilities include various customary restrictive covenants, including restrictions related to the ratio of debt to earnings before interest expense, taxes, depreciation and amortization (leverage ratio) and the ratio of earnings before interest expense, taxes, depreciation and amortization to interest expense (coverage ratio). Compliance with these covenants is determined quarterly based on the operating cash flows for the last four quarters.

On August 25, 2015, Olin entered into a Credit Agreement (the Credit Agreement) with a syndicate of lenders and Sumitomo Mitsui Banking Corporation, as administrative agent, in connection with the Transactions. The Credit Agreement provides for a term credit facility (the Sumitomo Credit Facility) under which Olin obtained term loans in an aggregate amount of $600.0 million. Loans under the Credit Agreement were made available and borrowed upon on the Closing Date. The Sumitomo Credit Facility will mature three years after the Closing Date and will have no scheduled amortization payments. The proceeds of the Sumitomo Credit Facility were used to refinance existing Spinco indebtedness outstanding, to pay fees and expenses in connection with the Transactions and for general corporate purposes. On November 3, 2015, we entered into an amendment to the Sumitomo Credit Facility, which upon effectiveness will increase the aggregate amount of term loans by $200.0 million which is expected to be drawn upon on November 5, 2015. The proceeds will be used to pay fees and expenses in connection with the Transactions and for general corporate purposes. The Credit Agreement contains customary representations, warranties and affirmative and negative covenants which are substantially similar to those included in Olin’s existing senior credit facilities in respect of the Transactions.

On March 26, 2015, we and certain financial institutions executed commitment letters pursuant to which the financial institutions agreed to provide financing to Spinco to finance the amount of the Cash and Debt Distribution and to provide financing, if needed, to Olin to refinance certain of our existing debt (the Bridge Financing), in each case on the terms and conditions set forth in the commitment letters. The Bridge Financing was not drawn on to facilitate the Transactions, and the commitments for the Bridge Financing have been terminated as of the Closing Date. For the nine months ended September 30, 2015, we paid debt issuance costs of $19.7 million associated with the Bridge Financing, which are included in interest expense.

During 2015, we expect to incur one-time costs in connection with the Merger and related transactions, including approximately $65 million of advisory, legal, accounting, integration and other professional fees, approximately $45 million of costs associated with the change in control mandatory acceleration of expenses under deferred compensation plans as a result of the Transactions and approximately $30 million of financing-related fees. For the three and nine months ended September 30, 2015, acquisition-related costs included $14.5 million and $35.4 million, respectively, associated with advisory, legal, accounting, integration and other professional fees, and interest expense included $7.7 million and $19.7 million, respectively, for acquisition financing expenses.

On December 12, 2014, we announced that we had made the decision to permanently close the portion of the Becancour, Canada chlor alkali facility that has been shut down since late June 2014. This action reduces the facility’s chlor alkali capacity by 185,000 tons. Subsequent to the shutdown, the plant will predominantly focus on bleach and hydrochloric acid, which are value-added products, as well as caustic soda. In the fourth quarter of 2014, we recorded pretax restructuring charges of $10.0 million for the write-off of equipment and facility costs, employee severance and related benefit costs, lease and other contract termination costs and a non-cash pension curtailment charge related to these actions. For the three months ended September 30, 2015, we recorded pretax restructuring charges of $0.1 million for facility exit costs related to these actions. For the nine months ended September 30, 2015, we recorded pretax restructuring charges of $1.7 million for the write-off of equipment and facility costs, lease and other contract termination costs, facility exit costs and a non-cash pension curtailment charge related to these actions. We expect to incur additional restructuring charges through 2016 of approximately $4.0 million related to the shut down of this portion of the facility.

On December 9, 2010, our board of directors approved a plan to eliminate our use of mercury in the manufacture of chlor alkali products. Under the plan, the 260,000 tons of mercury cell capacity at our Charleston, TN facility was converted to 200,000 tons of membrane capacity capable of producing both potassium hydroxide and caustic soda. The board of directors also approved plans to reconfigure our Augusta, GA facility to manufacture bleach and distribute caustic soda, while discontinuing chlor alkali manufacturing at this site. The completion of these projects eliminated our chlor alkali production using mercury cell technology. For the three months ended September 30, 2014, we recorded pretax restructuring charges of $0.7 million for employee severance and related benefit costs, employee relocation costs and facility exit costs related to these actions. For the nine months ended September 30, 2014, we recorded pretax restructuring charges of $3.0 million for employee severance and related benefit costs, employee relocation costs, facility exit costs and write-off of equipment and facility related to these actions.

On November 3, 2010, we announced that we made the decision to relocate the Winchester centerfire pistol and rifle ammunition manufacturing operations from East Alton, IL to Oxford, MS. This relocation, when completed, is forecast to reduce Winchester’s annual operating costs by approximately $35 million to $40 million. Consistent with this decision we initiated an estimated $110 million five-year project, which includes approximately $80 million of capital spending. The capital spending was partially financed by $31 million of grants provided by the State of Mississippi and local governments. We currently expect to complete this relocation by the end of 2016. For the three months ended September 30, 2015 and 2014, we recorded pretax restructuring charges of $0.2 million and $0.5 million, respectively, for employee severance and related benefit costs, employee relocation costs and facility exit costs related to these actions. For the nine months ended September 30, 2015 and 2014, we recorded pretax restructuring charges of $0.5 million and $1.5 million, respectively, for employee severance and related benefit costs, employee relocation costs and facility exit costs related to these actions. We expect to incur additional restructuring charges through 2016 of approximately $1.0 million related to the transfer of these operations.



		Employee severance and job related benefits			Lease and other contract termination costs			Employee relocation costs			Facility exit costs			Write-off of equipment and facility			Total
		($ in millions)
Balance at January 1, 2014		$	10.2		$	—		$	—		$	—		$	—		$	10.2
	Restructuring charges:
	First quarter	0.2			—			0.1			0.7			—			1.0
	Second quarter	1.2			—			—			0.8			0.3			2.3
	Third quarter	0.5			—			0.3			0.4			—			1.2
	Amounts utilized	(1.9		)	—			(0.4		)	(1.9		)	(0.3		)	(4.5		)
Balance at September 30, 2014		$	10.2		$	—		$	—		$	—		$	—		$	10.2
Balance at January 1, 2015		$	11.2		$	4.5		$	—		$	—		$	—		$	15.7
	Restructuring charges:
	First quarter	—			0.7			0.1			0.2			0.2			1.2
	Second quarter	—			—			0.2			0.2			0.3			0.7
	Third quarter	—			—			0.1			0.2			—			0.3
	Amounts utilized	(5.2		)	(2.8		)	(0.4		)	(0.6		)	(0.5		)	(9.5		)
	Currency translation adjustments	(0.5		)	(0.2		)	—			—			—			(0.7		)
Balance at September 30, 2015		$	5.5		$	2.2		$	—		$	—		$	—		$	7.7

The following table summarizes the cumulative restructuring charges of these 2014 and 2010 restructuring actions by major component through September 30, 2015:



	Chlor Alkali Products				Winchester		Total
	Becancour		Mercury		Winchester		Total
	($ in millions)
Write-off of equipment and facility	$	3.5	$	17.8	$	—	$	21.3
Employee severance and job related benefits	2.3		5.6		13.1		21.0
Facility exit costs	0.3		15.6		2.2		18.1
Pension and other postretirement benefits curtailment	0.4		—		4.1		4.5
Employee relocation costs	—		0.9		5.1		6.0
Lease and other contract termination costs	5.2		0.7		—		5.9
Total cumulative restructuring charges	$	11.7	$	40.6	$	24.5	$	76.8

During the nine months ended September 30, 2014, we made a payment of $5.5 million to resolve certain indemnity obligations related to the sale. As a result of the favorable resolution, we recognized a pretax gain of $4.6 million included in income from discontinued operations. The tax provision from discontinued operations included expense of $2.2 million for changes in tax contingencies related to the Metals sale. Income from discontinued operations, net consisted of the following:

We evaluate the collectibility of accounts receivable based on a combination of factors. We estimate an allowance for doubtful accounts as a percentage of net sales based on historical bad debt experience. This estimate is periodically adjusted when we become aware of a specific customer’s inability to meet its financial obligations (e.g., bankruptcy filing) or as a result of changes in the overall aging of accounts receivable. While we have a large number of customers that operate in diverse businesses and are geographically dispersed, a general economic downturn in any of the industry segments in which we operate could result in higher than expected defaults, and, therefore, the need to revise estimates for the provision for doubtful accounts could occur.

Inventories are valued at the lower of cost or market. The Chlor Alkali Products and Winchester segments inventory costs are determined principally by the dollar value last-in, first-out (LIFO) method of inventory accounting. The Chemical Distribution segment inventory costs are determined principally by the first-in, first-out (FIFO) method of inventory accounting. Cost for other inventories has been determined principally by the average cost method, primarily operating supplies, spare parts and maintenance parts. Elements of costs in inventories included raw materials, direct labor and manufacturing overhead. Inventories under the LIFO method are based on annual estimates of quantities and costs as of year-end; therefore, the condensed financial statements at September 30, 2015 reflect certain estimates relating to inventory quantities and costs at December 31, 2015. The replacement cost of our inventories would have been approximately $63.5 million, $65.7 million and $76.3 million higher than reported at September 30, 2015, December 31, 2014 and September 30, 2014, respectively.



	September 30, 2015		December 31, 2014		September 30, 2014
	($ in millions)
Investments in non-consolidated affiliates	$	24.6	$	23.3	$	23.0
Intangible assets (less accumulated amortization of $53.6, $42.6 and $38.9)	112.5		123.5		127.2
Deferred debt issuance costs	9.0		10.3		11.1
Bleach joint venture receivable	1.8		7.8		9.7
Income tax receivable	1.5		6.6		6.6
Interest rate swaps	—		3.5		4.1
Other	18.3		16.4		16.0
Other assets	$	167.7	$	191.4	$	197.7



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Computation of Income per Share	($ and shares in millions, except per share data)
Income from continuing operations, net	$	5.9	$	26.1	$	61.3	$	92.2
Income from discontinued operations, net	—		—		—		0.7
Net income	$	5.9	$	26.1	$	61.3	$	92.9
Basic shares	77.6		78.4		77.5		78.8
Basic income per share:
Income from continuing operations, net	$	0.08	$	0.33	$	0.79	$	1.17
Income from discontinued operations, net	—		—		—		0.01
Net income	$	0.08	$	0.33	$	0.79	$	1.18
Diluted shares:
Basic shares	77.6		78.4		77.5		78.8
Stock-based compensation	0.7		1.1		1.0		1.2
Diluted shares	78.3		79.5		78.5		80.0
Diluted income per share:
Income from continuing operations, net	$	0.08	$	0.33	$	0.78	$	1.15
Income from discontinued operations, net	—		—		—		0.01
Net income	$	0.08	$	0.33	$	0.78	$	1.16

We are party to various government and private environmental actions associated with past manufacturing facilities and former waste disposal sites. Charges to income for investigatory and remedial efforts were material to operating results in 2015 and 2014. The condensed balance sheets included reserves for future environmental expenditures to investigate and remediate known sites amounting to $139.9 million, $138.3 million and $139.7 million at September 30, 2015, December 31, 2014 and September 30, 2014, respectively, of which $120.9 million, $119.3 million and $121.7 million, respectively, were classified as other noncurrent liabilities.

Environmental exposures are difficult to assess for numerous reasons, including the identification of new sites, developments at sites resulting from investigatory studies, advances in technology, changes in environmental laws and regulations and their application, changes in regulatory authorities, the scarcity of reliable data pertaining to identified sites, the difficulty in assessing the involvement and financial capability of other potentially responsible parties (PRPs), our ability to obtain contributions from other parties and the lengthy time periods over which site remediation occurs. It is possible that some of these matters (the outcomes of which are subject to various uncertainties) may be resolved unfavorably to us, which could materially adversely affect our financial position or results of operations.

We, and our subsidiaries, are defendants in various legal actions (including proceedings based on alleged exposures to asbestos) incidental to our past and current business activities. As of September 30, 2015, December 31, 2014 and September 30, 2014, our condensed balance sheets included liabilities for these legal actions of $22.7 million, $22.1 million and $22.6 million, respectively. These liabilities do not include costs associated with legal representation. Based on our analysis, and considering the inherent uncertainties associated with litigation, we do not believe that it is reasonably possible that these legal actions will materially adversely affect our financial position, cash flows or results of operations.

During the ordinary course of our business, contingencies arise resulting from an existing condition, situation or set of circumstances involving an uncertainty as to the realization of a possible gain contingency. In certain instances such as environmental projects, we are responsible for managing the cleanup and remediation of an environmental site. There exists the possibility of recovering a portion of these costs from other parties. We account for gain contingencies in accordance with the provisions of Accounting Standards Codification (ASC) 450 “Contingencies” (ASC 450) and therefore do not record gain contingencies and recognize income until it is earned and realizable.

For the nine months ended September 30, 2015 we recognized insurance recoveries of $52.2 million for property damage and business interruption related to the portion of the Becancour, Canada chlor alkali facility that has been shut down since late June 2014. Cost of goods sold was reduced by $9.0 million and selling and administration was reduced by $0.9 million for the reimbursement of costs incurred and expensed in prior periods and other operating (expense) income included a gain of $42.3 million. The condensed statement of cash flows for the nine months ended September 30, 2015 included $24.0 million for the property damage portion of the insurance recoveries within proceeds from disposition of property, plant and equipment and gains on disposition of property, plant and equipment.

On April 24, 2014, our board of directors authorized a new share repurchase program for up to 8 million shares of common stock that will terminate in three years for any of the remaining shares not yet repurchased. This authorization replaced the July 2011 share repurchase program. For the nine months ended September 30, 2015, no shares were purchased and retired. For the nine months ended September 30, 2014, 1.7 million shares were purchased and retired at a cost of $44.7 million. As of September 30, 2015, we had purchased a total of 1.9 million shares under the April 2014 program, and 6.1 million shares remained authorized to be purchased. Under the Merger Agreement relating to our acquisition of the Acquired Business, we were restricted from repurchasing shares of our common stock prior to the consummation of the Merger. For a period of two years subsequent to the Closing Date of the Merger, we will continue to be subject to certain restrictions on our ability to conduct share repurchases, subject to certain exceptions.



	Foreign Currency Translation Adjustment			Unrealized Gains (Losses) on Derivative Contracts (net of taxes)			Pension and Postretirement Benefits (net of taxes)			Accumulated Other Comprehensive Loss
	($ in millions)
Balance at January 1, 2014	$	(0.5	)	$	0.9		$	(365.5	)	$	(365.1	)
Unrealized gains (losses):
First quarter	0.7			(5.7		)	—			(5.0		)
Second quarter	0.3			3.7			—			4.0
Third quarter	(1.5		)	(3.2		)	—			(4.7		)
Reclassification adjustments into income:
First quarter	—			0.6			6.5			7.1
Second quarter	—			0.9			6.8			7.7
Third quarter	—			(0.1		)	5.5			5.4
Tax benefit (provision):
First quarter	—			2.0			(2.5		)	(0.5		)
Second quarter	—			(1.8		)	(2.8		)	(4.6		)
Third quarter	—			1.3			(2.0		)	(0.7		)
Net Change	(0.5		)	(2.3		)	11.5			8.7
Balance at September 30, 2014	$	(1.0	)	$	(1.4	)	$	(354.0	)	$	(356.4	)
Balance at January 1, 2015	$	(2.3	)	$	(4.2	)	$	(436.6	)	$	(443.1	)
Unrealized (losses) gains:
First quarter	(1.4		)	(2.4		)	—			(3.8		)
Second quarter	0.3			(2.2		)	—			(1.9		)
Third quarter	(1.7		)	(6.4		)	—			(8.1		)
Reclassification adjustments into income:
First quarter	—			1.9			8.6			10.5
Second quarter	—			1.8			8.4			10.2
Third quarter	—			3.0			8.0			11.0
Tax benefit (provision):
First quarter	—			0.2			(3.5		)	(3.3		)
Second quarter	—			0.2			(3.1		)	(2.9		)
Third quarter	—			1.3			(3.1		)	(1.8		)
Net Change	(2.8		)	(2.6		)	15.3			9.9
Balance at September 30, 2015	$	(5.1	)	$	(6.8	)	$	(421.3	)	$	(433.2	)

We define segment results as income (loss) from continuing operations before interest expense, interest income, other operating (expense) income, other (expense) income and income taxes, and include the operating results of non-consolidated affiliates. Intersegment sales of $20.5 million and $21.8 million for the three months ended September 30, 2015 and 2014, respectively, and $67.5 million and $67.2 million for the nine months ended September 30, 2015 and 2014, respectively, have been eliminated. These represent the sale of caustic soda, bleach, potassium hydroxide and hydrochloric acid between Chemical Distribution and Chlor Alkali Products, at prices that approximate market.



	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Sales:	($ in millions)
Chlor Alkali Products	$	299.7		$	329.2		$	887.1		$	996.0
Chemical Distribution	72.6			76.6			212.7			221.4
Winchester	181.8			209.6			554.7			591.2
Intersegment sales elimination	(20.5		)	(21.8		)	(67.5		)	(67.2		)
Total sales	$	533.6		$	593.6		$	1,587.0		$	1,741.4
Income (loss) from continuing operations before taxes:
Chlor Alkali Products	$	14.1		$	26.2		$	62.2		$	101.3
Chemical Distribution	3.3			0.8			6.7			—
Winchester	30.1			38.5			93.8			109.9
Corporate/other:
Pension income	7.3			8.8			21.8			24.2
Environmental expense	(7.3		)	(1.6		)	(13.1		)	(6.3		)
Other corporate and unallocated costs	(9.2		)	(12.7		)	(44.5		)	(44.6		)
Restructuring charges	(0.3		)	(1.2		)	(2.2		)	(4.5		)
Acquisition-related costs	(14.5		)	(1.0		)	(35.4		)	(1.4		)
Other operating (expense) income	(0.1		)	—			42.1			0.8
Interest expense	(14.4		)	(17.7		)	(39.7		)	(37.0		)
Interest income	0.3			0.2			0.9			0.9
Income from continuing operations before taxes	$	9.3		$	40.3		$	92.6		$	143.3

Dividend yield for 2015 and 2014 was based on a historical average. Risk-free interest rate was based on zero coupon U.S. Treasury securities rates for the expected life of the options. Expected volatility was based on our historical stock price movements, as we believe that historical experience is the best available indicator of the expected volatility. Expected life of the option grant was based on historical exercise and cancellation patterns, as we believe that historical experience is the best estimate of future exercise patterns.

Most of our employees participate in defined contribution pension plans. We provide a contribution to an individual retirement contribution account maintained with the Contributing Employee Ownership Plan (CEOP) primarily equal to 5% of the employee’s eligible compensation if such employee is less than age 45, and 7.5% of the employee’s eligible compensation if such employee is age 45 or older. The defined contribution pension plans expense was $4.0 million and $4.2 million for the three months ended September 30, 2015 and 2014, respectively, and $12.9 million and $12.6 million for the nine months ended September 30, 2015 and 2014, respectively.

A portion of our bargaining hourly employees continue to participate in our domestic qualified defined benefit pension plans under a flat-benefit formula. Our funding policy for the qualified defined benefit pension plans is consistent with the requirements of federal laws and regulations. Our foreign subsidiaries maintain pension and other benefit plans, which are consistent with statutory practices. Our qualified defined benefit pension plan provides that if, within three years following a change of control of Olin, any corporate action is taken or filing made in contemplation of, among other things, a plan termination or merger or other transfer of assets or liabilities of the plan, and such termination, merger, or transfer thereafter takes place, plan benefits would automatically be increased for affected participants (and retired participants) to absorb any plan surplus (subject to applicable collective bargaining requirements).



	Pension Benefits						Other Postretirement Benefits
	Three Months Ended September 30,						Three Months Ended September 30,
	2015			2014			2015		2014
Components of Net Periodic Benefit (Income) Cost	($ in millions)
Service cost	$	1.5		$	1.3		$	0.3	$	0.2
Interest cost	20.5			21.5			0.4		0.5
Expected return on plans’ assets	(35.4		)	(34.8		)	—		—
Recognized actuarial loss	7.4			5.4			0.6		0.1
Net periodic benefit (income) cost	$	(6.0	)	$	(6.6	)	$	1.3	$	0.8



	Pension Benefits						Other Postretirement Benefits
	Nine Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015		2014
Components of Net Periodic Benefit (Income) Cost	($ in millions)
Service cost	$	4.4		$	4.0		$	0.9	$	0.8
Interest cost	61.7			64.9			1.7		2.0
Expected return on plans’ assets	(106.7		)	(104.6		)	—		—
Amortization of prior service cost	0.1			0.1			—		(0.1		)
Recognized actuarial loss	22.3			16.7			2.4		2.1
Curtailment	0.1			—			0.1		—
Net periodic benefit (income) cost	$	(18.1	)	$	(18.9	)	$	5.1	$	4.8



	Three Months Ended September 30,				Nine Months Ended September 30,
Effective Tax Rate Reconciliation (Percent)	2015		2014		2015		2014
Statutory federal tax rate	35.0	%	35.0	%	35.0	%	35.0	%
Foreign rate differential	0.3		(0.2	)	(0.1	)	(0.2	)
Domestic manufacturing/export tax incentive	(2.6	)	(1.7	)	(1.7	)	(2.1	)
Return to provision	0.2		(0.3	)	(1.1	)	(0.8	)
Dividends paid to CEOP	(0.6	)	(0.6	)	(0.6	)	(0.4	)
State income taxes, net	2.3		1.7		0.9		2.0
Remeasurement of deferred taxes	—		—		0.3		0.3
Change in valuation allowance	1.4		1.0		1.3		1.7
Change in tax contingencies	0.5		0.8		—		—
Other, net	0.1		(0.5	)	(0.2	)	0.2
Effective tax rate	36.6	%	35.2	%	33.8	%	35.7	%

The effective tax rate from continuing operations for the three and nine months ended September 30, 2015 included a benefit of less than $0.1 million and $1.1 million, respectively, associated with a return to provision adjustment for the finalization of our prior years’ U.S. federal and state income tax returns. The effective tax rate from continuing operations for the nine months ended September 30, 2015 also included an expense of $0.3 million related to the remeasurement of deferred taxes due to an increase in state effective tax rates.

The effective tax rate from continuing operations for the nine months ended September 30, 2014 included a benefit of $1.2 million associated with return to provision adjustments for the finalization of our 2013 U.S. federal and state income tax returns. The effective tax rate from continuing operations for the nine months ended September 30, 2014 also included $1.6 million of expense primarily associated with increases in valuation allowances on certain state tax credit carryforwards associated with a change in a state tax law and $0.5 million of expense related to the remeasurement of deferred taxes due to an increase in state effective tax rates.

As of September 30, 2015, we had $35.0 million of gross unrecognized tax benefits, which would have a net $33.5 million impact on the effective tax rate from continuing operations, if recognized. As of September 30, 2014, we had $36.5 million of gross unrecognized tax benefits, of which $34.8 million would have impacted the effective tax rate from continuing operations, if recognized. The amount of unrecognized tax benefits was as follows:

We operate primarily in North America and file income tax returns in numerous jurisdictions. Our tax returns are subject to examination by various federal, state and local tax authorities. Our U.S. federal income tax returns are under examination by the Internal Revenue Service (IRS) for tax years 2008 and 2010 to 2012. Our Canadian federal income tax returns are under examination by Canada Revenue Authority (CRA) for tax years 2010 and 2011. Our Canadian provincial income tax returns are under examination by Quebec Revenue Authority for tax years 2008 to 2011. We believe we have adequately provided for all tax positions; however, amounts asserted by taxing authorities could be greater than our accrued positions. For our primary tax jurisdictions, the tax years that remain subject to examination are as follows:

We are exposed to market risk in the normal course of our business operations due to our purchases of certain commodities, our ongoing investing and financing activities and our operations that use foreign currencies. The risk of loss can be assessed from the perspective of adverse changes in fair values, cash flows and future earnings. We have established policies and procedures governing our management of market risks and the use of financial instruments to manage exposure to such risks. ASC 815 “Derivatives and Hedging” (ASC 815) requires an entity to recognize all derivatives as either assets or liabilities in the statement of financial position and measure those instruments at fair value. We use hedge accounting treatment for substantially all of our business transactions whose risks are covered using derivative instruments. In accordance with ASC 815, we designate commodity forward contracts as cash flow hedges of forecasted purchases of commodities and certain interest rate swaps as fair value hedges of fixed-rate borrowings. We do not enter into any derivative instruments for trading or speculative purposes.

Energy costs, including electricity used in our Chlor Alkali Products segment, and certain raw material and energy costs, namely copper, lead, zinc, electricity and natural gas used in our Winchester and Chemical Distribution segments, are subject to price volatility. Depending on market conditions, we may enter into futures contracts and put and call option contracts in order to reduce the impact of commodity price fluctuations. The majority of our commodity derivatives expire within one year. Those commodity contracts that extend beyond one year correspond with raw material purchases for long-term fixed-price sales contracts.

In March 2010, we entered into interest rate swaps on $125 million of our underlying fixed-rate debt obligations, whereby we agreed to pay variable rates to a counterparty who, in turn, pays us fixed rates. The counterparty to these agreements is Citibank, N.A. (Citibank), a major financial institution. In October 2011, we entered into $125 million of interest rate swaps with equal and opposite terms as the $125 million variable interest rate swaps on the 6.75% senior notes due 2016 (2016 Notes). We have agreed to pay a fixed rate to a counterparty who, in turn, pays us variable rates. The counterparty to these agreements is also Citibank. The result was a gain of $11.0 million on the $125 million variable interest rate swaps, which will be recognized through 2016. As of September 30, 2015, $1.9 million of this gain was included in current installments of long-term debt. In October 2011, we de-designated our $125 million interest rate swaps that had previously been designated as fair value hedges. The $125 million variable interest rate swaps and the $125 million fixed interest rate swaps do not meet the criteria for hedge accounting. All changes in the fair value of these interest rate swaps are recorded currently in earnings.

ASC 815 requires that all derivative instruments be recorded on the balance sheet at their fair value. For derivative instruments that are designated and qualify as a cash flow hedge, the change in fair value of the derivative is recognized as a component of other comprehensive income until the hedged item is recognized in earnings. Gains and losses on the derivatives representing hedge ineffectiveness are recognized currently in earnings.

We use cash flow hedges for certain raw material and energy costs such as copper, zinc, lead, electricity and natural gas to provide a measure of stability in managing our exposure to price fluctuations associated with forecasted purchases of raw materials and energy used in the company’s manufacturing process. At September 30, 2015, we had open positions in futures contracts through 2021. If all open futures contracts had been settled on September 30, 2015, we would have recognized a pretax loss of $11.4 million.

For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. We include the gain or loss on the hedged items (fixed-rate borrowings) in the same line item, interest expense, as the offsetting loss or gain on the related interest rate swaps. We had no interest rate swaps designated as fair value hedges as of September 30, 2015, December 31, 2014 and September 30, 2014.

In June 2012, we terminated $73.1 million of interest rate swaps with Wells Fargo that had been entered into on the SunBelt Notes in May 2011. The result was a gain of $2.2 million, which will be recognized through 2017. As of September 30, 2015, $0.5 million of this gain was included in long-term debt. Pursuant to a note purchase agreement dated December 22, 1997, the SunBelt Chlor Alkali Partnership (SunBelt) sold $97.5 million of Guaranteed Senior Secured Notes due 2017, Series O, and $97.5 million of Guaranteed Senior Secured Notes due 2017, Series G. We refer to these notes as the SunBelt Notes. The SunBelt Notes bear interest at a rate of 7.23% per annum, payable semi-annually in arrears on each June 22 and December 22.

We use interest rate swaps as a means of managing interest expense and floating interest rate exposure to optimal levels. These interest rate swaps are treated as fair value hedges. The accounting for gains and losses associated with changes in fair value of the derivative and the effect on the condensed financial statements will depend on the hedge designation and whether the hedge is effective in offsetting changes in fair value of cash flows of the asset or liability being hedged.



	Asset Derivatives										Liability Derivatives
		Fair Value										Fair Value
Derivatives Designated as Hedging Instruments	Balance Sheet Location	September 30, 2015			December 31, 2014			September 30, 2014			Balance Sheet Location	September 30, 2015		December 31, 2014			September 30, 2014
		($ in millions)										($ in millions)
Interest rate contracts	Other current assets	$	—		$	—		$	—		Current installments of long-term debt	$	1.9	$	—		$	—
Interest rate contracts	Other assets	—			—			—			Long-term debt	0.5		4.5			5.2
Commodity contracts – losses	Other current assets	—			—			—			Accrued liabilities	11.4		7.2			3.7
Commodity contracts – gains	Other current assets	—			—			—			Accrued liabilities	—		(0.1		)	(1.1		)
		$	—		$	—		$	—			$	13.8	$	11.6		$	7.8
Derivatives Not Designated as Hedging Instruments
Interest rate contracts - gains	Other current assets	$	2.1		$	—		$	—		Accrued liabilities	$	—	$	—		$	—
Interest rate contracts - losses	Other current assets	(0.4		)	—			—			Accrued liabilities	—		—			—
Interest rate contracts – gains	Other assets	—			4.3			4.9			Other liabilities	—		—			—
Interest rate contracts – losses	Other assets	—			(0.8		)	(0.8		)	Other liabilities	—		—			—
Commodity contracts – losses	Other current assets	—			—			—			Accrued liabilities	0.4		1.5			0.5
		$	1.7		$	3.5		$	4.1			$	0.4	$	1.5		$	0.5
Total derivatives⁽¹⁾		$	1.7		$	3.5		$	4.1			$	14.2	$	13.1		$	8.3



Virginia	13-1872319
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)



190 Carondelet Plaza, Suite 1530, Clayton, MO	63105
(Address of principal executive offices)	(Zip Code)



	September 30, 2015			December 31, 2014			September 30, 2014
	($ in millions)
Supplies	$	45.7		$	39.2		$	42.2
Raw materials	67.9			63.3			66.9
Work in process	29.0			31.8			35.5
Finished goods	153.4			141.5			130.5
	296.0			275.8			275.1
LIFO reserve	(63.5		)	(65.7		)	(76.3		)
Inventories, net	$	232.5		$	210.1		$	198.8



Grant date	2015			2014
Dividend yield	2.92		%	3.13		%
Risk-free interest rate	1.69		%	2.13		%
Expected volatility	34		%	42		%
Expected life (years)	6.0			7.0
Weighted average grant fair value (per option)	$	6.80		$	8.34
Weighted average exercise price	$	27.40		$	25.69
Shares granted	776,750			624,200



	Tax Years
U.S. federal income tax	2008; 2010 – 2014
U.S. state income tax	2006 – 2014
Canadian federal income tax	2010 – 2014
Canadian provincial income tax	2008 – 2014



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



	September 30,
	2015			2014
	($ in millions)
Balance at beginning of year	$	3.0		$	3.4
Provisions (credited) charged	(0.4		)	0.5
Write-offs, net of recoveries	(0.1		)	(0.4		)
Balance at end of period	$	2.5		$	3.5


(1)	Does not include the impact of cash collateral received from or provided to counterparties.



		Amount of Gain (Loss)						Amount of Gain (Loss)
		Three Months Ended September 30,						Nine Months Ended September 30,
	Location of Gain (Loss)	2015			2014			2015			2014
Derivatives – Cash Flow Hedges		($ in millions)
Recognized in other comprehensive loss (effective portion)	———	$	(6.4	)	$	(3.2	)	$	(11.0	)	$	(5.2	)

Reclassified from accumulated other comprehensive loss into income (effective portion)	Cost of goods sold	$	(3.0	)